Antimicrobials with the potential to act as immune stimulators and overcome bacterial resistance are emerging as important alternative approaches to fighting antimicrobial resistance The novel ...

C. difficile infection recurrence rates were numerically lower with vancomycin than with placebo, though the difference was not significant. However, the results could be clinically meaningful, an ...

In a recent review published in the Microorganisms Journal, researchers reviewed existing data on the use of probiotics and antimicrobial peptides (AMPs) against multi-drug-resistant (MDR) bacteria, ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization. A recent study has demonstrated ...

This study was conducted at St. Mary's Hospital, a small community-based institution with approximately 200 beds, serving an urban population in Waterbury, Connecticut. Our catchment area included a ...

Vancomycin is a common antibiotic used to treat gram-positive bacterial infections. It targets a key building block of the bacterial cell wall called Lipid II, but it can’t reach this lipid in ...

Antibiotic resistance is a major concern, particularly for immunocompromised patients, who are at greater risk of serious infections. Microbiota composition can help prevent pathogenic bacteria from ...

Enterococci, while part of a normal healthy microbiome, can also be significant human pathogens with an increasing role in Healthcare Associated Infection (HAI). They are major contributors to ...